Material Agreements

NEXTNAV INC. entered into Asset Purchase Agreement with Telesaurus Holdings GB and Skybridge Spectrum Foundation valued at up to $50,000,000 (effective 2024-03-07).

“On March 7, 2024, NextNav Inc. (“NextNav”) and its wholly-owned subsidiary Progeny LMS, LLC (the “Company”) entered into an Asset Purchase Agreement (the “Agreement”) with Telesaurus Holdings GB (“Telesaurus”) and Skybridge Spectrum Foundation (“Skybridge”), pursuant to which the Company will acquire (1) Multilateration Location and Monitoring Service (“M-LMS”) licenses (the “Licenses”) issued by the Federal Communications Commission (the “FCC”) and (2) rights to a petition for reconsideration, dated December 20, 2017, which, if granted, may reinstate additional M-LMS licenses owned by Skybridge and Telesaurus and terminated by the FCC in 2017, for an aggregate purchase price of up to $50,000,000 paid in the form of cash and NextNav common stock”

Rigel Resource Acquisition Corp. entered into Exchange Agreement with Newco, Blyvoor Gold Proprietary Limited, Orion Mine Finance Fund II L.P., and the Target Companies (effective 2024-03-11).

“Concurrently with the execution of the Business Combination Agreement, Newco also entered into an Exchange Agreement (the “ Exchange Agreement ”), by and among, Newco, Blyvoor Gold Proprietary Limited, a South African private limited liability company (“ Blyvoor Gold ”), Orion Mine Finance Fund II L.P., a Bermuda limited partnership (“ Orion ” and, together with Blyvoor Gold, the “ Sellers ”), and the Target Companies.”

Rigel Resource Acquisition Corp. entered into Business Combination Agreement with Rigel, Blyvoor Gold Resources Proprietary Limited, Blyvoor Gold Operations Proprietary Limited, RRAC NewCo, and RRAC Merger Sub (effective 2024-03-11).

“On March 11, 2024, Rigel Resource Acquisition Corp, a Cayman Islands exempted company (“ Rigel ”), entered into a Business Combination Agreement (the “ Business Combination Agreement ”), by and among Rigel, Blyvoor Gold Resources Proprietary Limited, a South African private limited liability company (“ Blyvoor Resources ”), Blyvoor Gold Operations Proprietary Limited, a South African private limited liability company (“ Tailings ” and, together with Blyvoor Resources, the “ Target Companies ”, each a “ Target Company ”), RRAC NewCo, a Cayman Islands exempted company and wholly-owned subsidiary of Rigel (“ Newco ”), and RRAC Merger Sub, a Cayman Islands exempted company and wholly-owned subsidiary of Newco (“ Merger Sub ”).”

Mountain & Co. I Acquisition Corp. amended Trust Agreement Amendment No. 3 with Continental Stock Transfer & Trust Company (effective 2024-03-08).

“On March 8, 2024, upon the shareholders’ approval of the Trust Amendment Proposal (as defined below), Mountain & Co. I Acquisition Corp. (the “Company”), entered into an amendment (the “Trust Agreement Amendment No. 3”) to the Investment Management Trust Agreement, dated November 4, 2021 (as amended by Amendment No. 1 dated February 6, 2023 and Amendment No. 2 dated September 14, 2023, the “Trust Agreement”), by and between the Company and Continental Stock Transfer & Trust Company, as trustee, to allow the change of the date by which the Company must consummate its initial business combination from March 9, 2024 to November 9, 2024 (or such earlier date as determined by the Company’s board of directors) (the “Extension”).”

Alpha Teknova, Inc. amended Amendment No. 5 with MidCap Financial Trust valued at $52.135 million senior secured term loan and a $5.0 million working capital facility (effective 2024-03-08).

“On March 8, 2024, Alpha Teknova, Inc. (the “Company”) entered into limited waivers and amendments (collectively “Amendment No. 5”) to (i) the May 10, 2022, Amended and Restated Credit and Security Agreement (Term Loan)”

Greenidge Generation Holdings Inc. entered into Motus Agreement with a subsidiary of Motus Pivot Inc. valued at $1.45 million (effective 2024-03-06).

“On March 6, 2024, a subsidiary of Greenidge Generation Holdings Inc. (“ Greenidge ” or the " Company ") entered into a Commercial Purchase and Sale Agreement (the “ Motus Agreement ”) with a subsidiary of Motus Pivot Inc., a Delaware corporation (" Motus "), pursuant to which Greenidge has agreed to purchase from Motus a parcel of land containing approximately 12 acres located in Columbus, Mississippi, including over 73,000 square feet of industrial warehouse space (the “ Property ”).”

CONX Corp. entered into Purchase Agreement with EchoStar Real Estate Holding L.L.C. valued at $26.75 million (effective 2024-03-10).

“On March 10, 2024, CONX Corp. (the “Company”), a special purpose acquisition company, and EchoStar Real Estate Holding L.L.C. (“Seller”), a subsidiary of EchoStar Corporation, entered into a definitive purchase and sale agreement (the “Purchase Agreement”), which provides for the Company’s purchase from the Seller of the commercial real estate property (the “Property”) in Littleton, Colorado, comprising the corporate headquarters of DISH Wireless, for a purchase price of $26.75 million (the “Purchase Price” and such transaction, the “Transaction”).”

Definium Therapeutics, Inc. entered into Purchase Agreement with certain investors valued at approximately $70.3 million (effective 2024-03-07).

“Also on March 7, 2024, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with certain investors (the “Investors”), pursuant to which the Investors agreed to purchase, and the Company agreed to sell 12,500,000 common shares (the “Private Placement Shares”), at a price of $6.00 per Private Placement Share, in a private placement transaction (the “Private Placement”).”

Definium Therapeutics, Inc. entered into Underwriting Agreement with Leerink Partners LLC and Cantor Fitzgerald & Co., as representatives of the underwriters named therein valued at approximately $93.8 million (effective 2024-03-07).

“On March 7, 2024, Mind Medicine (MindMed) Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Leerink Partners LLC and Cantor Fitzgerald & Co., as representatives of the underwriters named therein (the “Underwriters”), in connection with the issuance and sale by the Company in an underwritten offering (the “Offering”) of 16,666,667 common shares”

Blue Owl Credit Income Corp. amended Amendment No. 7 with Core Income Funding II LLC (effective 2024-03-07).

“In connection with the CLO Transaction, on March 7, 2024, Core Income Funding II LLC, entered into Amendment No. 7 (the “Amendment” and the facility as amended, the “Secured Credit Facility”), which amended that certain Loan Financing and Servicing Agreement, dated as of October 5, 2021”

Blue Owl Credit Income Corp. entered into Collateral Management Agreement with Blue Owl Credit Advisors LLC (effective 2024-03-07).

“OCA will serve as collateral manager for the Issuer under a collateral management agreement dated as of the Closing Date (the “Collateral Management Agreement”).”

Blue Owl Credit Income Corp. entered into Core Income Funding II Loan Sale Agreement with Core Income Funding II LLC valued at approximately $356.49 million (effective 2024-03-07).

“The remainder of the initial portfolio assets securing the Secured Notes consisted of approximately $356.49 million funded par amount of middle market loans purchased by the Issuer from Core Income Funding II LLC, a wholly-owned subsidiary of the Company, under an additional loan sale agreement executed on the Closing Date between the Issuer and Core Income Funding II LLC (the “Core Income Funding II Loan Sale Agreement”).”

Blue Owl Credit Income Corp. entered into OCIC Loan Sale Agreement with Owl Rock CLO XVI, LLC valued at approximately $206.563 million (effective 2024-03-07).

“As part of the CLO Transaction, the Company entered into a loan sale agreement with the Issuer dated as of the Closing Date (the “OCIC Loan Sale Agreement”), which provided for the contribution of approximately $206.563 million funded par amount of middle market loans from the Company to the Issuer on the Closing Date and for future sales from the Company to the Issuer on an ongoing basis.”

Blue Owl Credit Income Corp. entered into Indenture with State Street Bank and Trust Company valued at $597 million (effective 2024-03-07).

“On March 7, 2024 (the “Closing Date”), Blue Owl Credit Income Corp. (the “Company”) completed a $597 million term debt securitization transaction (the “CLO Transaction”), also known as a collateralized loan obligation transaction, which is a form of secured financing incurred by the Company.”

Kiromic Biopharma, Inc. entered into 25% Senior Secured Convertible Promissory Note with an accredited investor valued at principal amount of $2,000,000 (effective 2024-03-07).

“On March 7, 2024, Kiromic BioPharma, Inc. (the “Company”) issued a 25% Senior Secured Convertible Promissory Note (the “Note”) to an accredited investor. The Note has a principal amount of $2,000,000”

Equitrans Midstream Corp entered into Agreement and Plan of Merger with EQT Corporation, Humpty Merger Sub Inc., Humpty Merger Sub LLC (effective 2024-03-10).

“On March 10, 2024, Equitrans Midstream Corporation, a Pennsylvania corporation (the Company), EQT Corporation, a Pennsylvania corporation (Parent), Humpty Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent (Merger Sub), and Humpty Merger Sub LLC, a Delaware limited liability company and an indirect wholly owned subsidiary of Parent (LLC Sub and, together with Merger Sub, Merger Subs), entered into an Agreement and Plan of Merger (the Merger Agreement)”

Arcosa, Inc. entered into Membership Interest Purchase Agreement with National Oilwell Varco, L.P. valued at approximately $180 million (effective 2024-03-08).

“On March 8, 2024, CEMC Services, LLC (“Purchaser”), a Delaware limited liability company and wholly owned subsidiary of Arcosa, Inc. (“Arcosa”), entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with National Oilwell Varco, L.P., a Delaware limited partnership (the “Seller”) and, solely for the purposes of Section VI.3(c) (Confidentiality) and Section VI.12 (Buyer Guarantor), Arcosa.”

Harpoon Therapeutics, Inc. terminated Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co. (effective 2024-03-11).

“As previously disclosed, on March 13, 2020, Harpoon entered into a Controlled Equity Offering SM Sales Agreement (the “Sales Agreement”) with Cantor Fitzgerald & Co.”

Axil Brands, Inc. entered into Repurchase Agreements with stockholders of the Company listed on the signature pages valued at $1,246,489.50 (effective 2024-03-05).

“Effective as of March 5, 2024, AXIL Brands, Inc. (the “Company”) entered into repurchase agreements (the “Repurchase Agreements”) with the stockholders of the Company listed on the signature pages thereto (the “Stockholders”) to purchase from the Stockholders in the aggregate 207,748,250 shares of Series A Preferred Stock of the Company (equivalent, in the aggregate, to approximately 10,387,413 shares of the Company’s common stock on an as converted basis) for the aggregate cash consideration of $1,246,489.50.”

California Resources Corp amended Amendment with Citibank, N.A., as administrative agent, collateral agent and issuing bank, and the several lenders party thereto (effective 2024-03-08).

“On March 8, 2024, California Resources Corporation (the “Company” or “CRC”) entered into a third amendment (the “Amendment”) to its Amended and Restated Credit Agreement, dated as of April 26, 2023, with Citibank, N.A., as administrative agent, collateral agent and issuing bank, and the several lenders party thereto (as amended, the “Revolving Credit Facility”).”

Goldman Sachs BDC, Inc. entered into Underwriting Agreement with Goldman Sachs Asset Management, L.P. and BofA Securities, Inc., as representative of the several underwriters valued at $400,000,000 aggregate principal amount of 6.375% notes due 2027 (effective 2024-03-06).

“On March 6, 2024, Goldman Sachs BDC, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) by and among the Company, Goldman Sachs Asset Management, L.P. and BofA Securities, Inc., as representative of the several underwriters named in Schedule A thereto (collectively, the “Underwriters”), in connection with the issuance and sale of $ 400,000,000 aggregate principal amount of the Company’s 6.375% notes due 2027 (the “Offering”).”

BIORA THERAPEUTICS, INC. entered into Registration Rights Agreement with the Purchaser (effective 2024-03-12).

“Also on the Closing Date, in connection with the Debt Exchange Transactions, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Purchaser, which provides that the Company will register the resale of all shares of Common Stock issuable upon conversion or exercise of, or otherwise issuable pursuant to, the Notes or the Warrants issued pursuant to the Note Exchange Agreement or the Note Purchase Agreement”

BIORA THERAPEUTICS, INC. entered into Note Purchase Agreement with the investor named therein (the “Purchaser”) valued at $2,812,500 (effective 2024-03-08).

“The Company also entered into a note purchase agreement (the “Note Purchase Agreement”), dated March 8, 2024, with the investor named therein (the “Purchaser”). Pursuant to the Note Purchase Agreement, the Purchaser agreed to purchase $2,812,500 in aggregate principal amount of additional Notes from the Company for cash at par value.”

BIORA THERAPEUTICS, INC. entered into Note Exchange Agreement with a holder of the Company’s 7.25% Convertible Senior Notes due 2025 valued at $5,625,000 (effective 2024-03-08).

“The Company entered into an exchange agreement (the “Note Exchange Agreement”), dated March 8, 2024, with a holder of the Company’s 7.25% Convertible Senior Notes due 2025 (the “Existing Notes”), pursuant to which the Company agreed to acquire an aggregate of $5,625,000 of the Company’s Existing Notes from the holder in exchange for (i) $3,825,000 in aggregate principal amount of 11.00% / 13.00% Convertible Senior Secured Notes due 2028 (the “Notes”), and (ii) accrued and unpaid interest on the Existing Notes exchanged to, but excluding, the Closing Date.”

Akari Therapeutics Plc entered into Purchase Agreement with certain existing investors valued at approximately $1,615,000 (effective 2024-03-11).

“On March 11, 2024, Akari Therapeutics, Plc (the “ Company ”) entered into a definitive agreement (the “ Purchase Agreement ”) with certain existing investors, pursuant to which the Company agreed to sell and issue in a private placement (the “ Private Placement ”) approximately $1,615,000 of unregistered American Depository Shares (“ ADSs ”)”

Propanc Biopharma, Inc. entered into Purchase Agreement with an investor valued at $50,000 (effective 2024-03-05).

“Effective March 5, 2024, Propanc Biopharma, Inc. (the “Company”) entered into and closed a securities purchase agreement (the “Purchase Agreement”) with an investor (the “Investor”), pursuant to which the Investor agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $50,000”

PetVivo Holdings, Inc. terminated ATM Agreement with ThinkEquity LLC valued at up to $2,500,000 (effective 2024-03-07).

“PetVivo Holdings, Inc. (the “Company”) and ThinkEquity, LLC mutually agreed to terminate the ATM Sales Agreement, dated as of August 23, 2023 (the “ATM Agreement”) between the Company and with ThinkEquity LLC (the “Agent”), effective as of March 7, 2024.”

Nixxy, Inc. amended Job Mobz Amendment with Job Mobz valued at one hundred thousand ($100,000) (effective 2024-03-07).

“On March 7, 2024, Job Mobz and the Company entered into an Amendment to the Asset Purchase Agreement (Exhibit 2.1) (“Job Mobz Amendment”).”

Scorpius Holdings, Inc. entered into Underwriting Agreement with ThinkEquity, LLC valued at $1.5 million (effective 2024-03-07).

“On March 7, 2024, Scorpius Holdings, Inc. (the “Company”) entered into an Underwriting Agreement (the “Agreement”) with ThinkEquity, LLC, as representative of the several underwriters named therein (the “Underwriters”), pursuant to which the Company agreed to issue and sell (the “Offering”) 10,000,000 shares (the “Shares”) of its common stock (the “Common Stock”), par value $0.0002 per share, at a price of $0.15 per share.”

Auto Parts 4Less Group, Inc. entered into NIM Agreement with North Industrial Machine, LLC valued at 54,997,800 shares of common stock for cancellation of $549,978 of indebtedness (effective 2024-03-07).

“On March 7, 2024, the Company entered into an Exchange Agreement (the “NIM Agreement”) with North Industrial Machine, LLC (“NIM”).”

Auto Parts 4Less Group, Inc. entered into Salzano Agreement with Sergio and Cheryl Salzano Family Trust valued at 64,590,000 shares of common stock for cancellation of $645,900 of indebtedness (effective 2024-03-06).

“On March 6, 2024, Auto Parts 4 Less Group, Inc., a Nevada corporation (the “Company”), entered into an Exchange Agreement (the “Salzano Agreement”) with Sergio and Cheryl Salzano Family Trust (“Salzano”).”

TANDEM DIABETES CARE INC entered into Indenture with U.S. Bank Trust Company, National Association valued at $316.25 million aggregate principal amount (effective 2024-03-08).

“Indenture and Notes On March 8, 2024, Tandem Diabetes Care, Inc. (the “Company”) completed its previously announced private offering (the “Offering”) of $316.25 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029”

Zerify, Inc. entered into Series D Exchange Agreement with Walleye Opportunities Master Fund Ltd. (effective 2024-02-26).

“on February 26, 2024, the Company entered into an exchange agreement (the “Series D Exchange Agreement”) with existing an existing investor, whereby the Company is to issue 460 shares of Series D Convertible Preferred Stock (the “Series D Preferred Stock”) in exchange for 1,838,800,003 issued and outstanding warrants.”

Zerify, Inc. entered into Series C Exchange Agreements (effective 2024-02-27).

“On February 27, 2024, Zerify, Inc., a Wyoming corporation (the “Company”), entered into seven separate exchange agreements (collectively, the “Series C Exchange Agreements”) with existing investors, whereby the Company is to issue a total of 5,496 shares of Series C Convertible Preferred Stock (the “Series C Preferred Stock”) in exchange for a total of 11,234,924,850 issued and outstanding warrants and a $1,000,000 promissory note.”

Unique Logistics International, Inc. amended Amended Original Seller Note with Unique Logistics Holdings Limited valued at $1,053,000 (effective 2024-03-06).

“Additionally, on March 6, 2024, the Company and ULHL amended the Original Seller Note (the “ Amended Original Seller Note ”), which extended the maturity date thereof from the second anniversary of the date of the Note to June 30, 2025 and increased the principal amount of the Note to $1,053,000.”

Unique Logistics International, Inc. amended Second Amended Second Net Assets Note with Unique Logistics Holdings Limited (effective 2024-03-05).

“On March 5, 2024, the Company and ULHL further amended the Amended Second Net Assets Note (the “ Second Amended Second Net Assets Note ”), which extended the maturity date thereof from March 31, 2025 to June 30, 2025.”

Unique Logistics International, Inc. entered into Note 12 with Unique Logistics Holdings Limited valued at $3,400,000 (effective 2024-03-05).

“On March 5, 2024, the Company and ULHL agreed to cancel, replace and supersede Note 9, in its entirety, in favor of (i) a promissory note in the aggregate principal amount of $2,500,000 (“ Note 11 ”) and (ii) a promissory note in the aggregate principal amount of $3,400,000 (“ Note 12 ”).”

Unique Logistics International, Inc. entered into Note 11 with Unique Logistics Holdings Limited valued at $2,500,000 (effective 2024-03-05).

“On March 5, 2024, the Company and ULHL agreed to cancel, replace and supersede Note 9, in its entirety, in favor of (i) a promissory note in the aggregate principal amount of $2,500,000 (“ Note 11 ”) and (ii) a promissory note in the aggregate principal amount of $3,400,000 (“ Note 12 ”).”

Unique Logistics International, Inc. terminated Note 9 with Unique Logistics Holdings Limited valued at $4,500,000 (effective 2024-03-05).

“On March 5, 2024, the Company and ULHL agreed to cancel, replace and supersede Note 9, in its entirety, in favor of (i) a promissory note in the aggregate principal amount of $2,500,000 (“ Note 11 ”) and (ii) a promissory note in the aggregate principal amount of $3,400,000 (“ Note 12 ”).”

Astra Energy, Inc. entered into Joint Venture Agreement with Powertron Global LLC (effective 2024-03-08).

“On March 08, 2024, Astra Energy Inc. (the “ Company ”) entered into a Joint Venture Agreement (the " Agreement ") with Powertron Global LLC (" Powertron ").”

DYADIC INTERNATIONAL INC entered into Securities Purchase Agreement with The Francisco Trust U/A/D February 28, 1996 and immediate family members and family trusts related to Mark Emalfarb valued at $6.0 million (effective 2024-03-08).

“On March 8, 2024, Dyadic International, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) pursuant to which the Company issued 8.0% Senior Secured Convertible Promissory Notes due March 8, 2027 in an aggregate principal amount of $6.0 million (the “Convertible Notes”).”

LEXICON PHARMACEUTICALS, INC. amended Fifth Amendment with Oxford Finance LLC (effective 2024-03-06).

“On March 6, 2024, the Company and one of its subsidiaries entered into a fifth amendment to its loan and security agreement (the “ Fifth Amendment ”) with Oxford Finance LLC and the lenders listed therein modifying the existing financial covenant relating to net sales of INPEFA ® (sotagliflozin).”

LEXICON PHARMACEUTICALS, INC. entered into Preferred Stock Purchase Agreement with certain accredited investors valued at approximately $250 million (effective 2024-03-11).

“On March 11, 2024, Lexicon Pharmaceuticals, Inc., a Delaware corporation (the “ Company ”), entered into a Preferred Stock Purchase Agreement (the “ Purchase Agreement ”) with certain accredited investors (the “ Purchasers ”).”

UNITED RENTALS NORTH AMERICA INC entered into Indenture with Truist Bank valued at $1,100,000,000 aggregate principal amount (effective 2024-03-11).

“United Rentals (North America), Inc. (“URNA”) completed an offering of $1,100,000,000 aggregate principal amount of its 6.125% Senior Notes due 2034 (the “Notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), or outside the United States to certain persons in reliance on Regulation S under the Securities Act. The Notes were issued pursuant to an indenture, dated as of March 11, 2024 (the “Indenture”), among URNA, United Rentals, Inc. (“URI”), certain domestic subsidiaries of URNA (the “Subsidiary Guarantors” and, together with URI, the “Guarantors”), and Truist Bank, as trustee.”

Strategy Inc entered into Purchase Agreement with Citigroup Global Markets Inc., as representative of the several initial purchasers named therein valued at $800 million (effective 2024-03-05).

“The notes were sold under a purchase agreement, dated as of March 5, 2024, entered into by and between the Company and Citigroup Global Markets Inc., as representative of the several initial purchasers named therein (the “Initial Purchasers”), for resale to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).”

Strategy Inc entered into Indenture with U.S. Bank Trust Company, National Association valued at $800 million (effective 2024-03-08).

“On March 8, 2024, the Company entered into an indenture (the “Indenture”) with respect to the notes with U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).”

CORE MOLDING TECHNOLOGIES INC amended First Amendment with The Huntington National Bank valued at $5,000,000 (effective 2024-03-07).

“On March 7, 2024, Core Molding Technologies, Inc. (the “Company”) entered into a First Amendment (the “First Amendment”) to the Credit Agreement dated July 22, 2022 (the “Credit Agreement”) with The Huntington National Bank, as administrative agent, sole lead arranger and sole bookrunner, and the lenders from time-to-time party thereto.”

WESCO INTERNATIONAL INC entered into Indenture for 6.375% Senior Notes due 2029 and 6.625% Senior Notes due 2032 with U.S. Bank Trust Company, National Association valued at $900 million 6.375% notes due 2029 and $850 million 6.625% notes due 2032 (effective 2024-03-07).

“On March 7, 2024, WESCO Distribution, Inc. (the “Issuer” or “Wesco Distribution”), a wholly owned subsidiary of WESCO International, Inc. (the “Company” or “WESCO”), completed its previously announced offering (the “Offering”) to eligible purchasers of $900 million aggregate principal amount of 6.375% senior notes due 2029 (the “5-Year Notes”) and $850 million aggregate principal amount of 6.625% senior notes due 2032 (the “8-Year Notes” and, together with the 5-Year Notes, the “Notes”).”

ALBEMARLE CORP entered into Deposit Agreement with Equiniti Trust Company, LLC (effective 2024-03-08).

“the Company entered into a deposit agreement (the “ Deposit Agreement ”), dated March 8, 2024, by and among the Company, Equiniti Trust Company, LLC, as depositary”

ALBEMARLE CORP entered into Articles of Amendment.

“the Company filed articles of amendment (the “ Articles of Amendment ”) to the Company’s Amended and Restated Articles of Incorporation with the State Corporation Commission of the Commonwealth of Virginia”